Michael I. D’Angelica

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Michael I. D’Angelica

Nov 5, 2024, 11:14 | Insight

Eileen M. O’Reilly: Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma

Eileen M. O’Reilly, Oncologist at Memorial Sloan Kettering Cancer Centre, shared on X: “Adjuvant mFOLFIRINOX…

Oct 29, 2024, 09:39 | Insight

Anirban Maitra: Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC) led by Eileen M O’Reilly

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared…

All: 2 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023